⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LQDA News
Liquidia Corporation Common Stock
Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
globenewswire.com
UTHR
GOSS
JNJ
MRK
LQDA
Form 8-K
sec.gov
LQDA
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
globenewswire.com
LQDA
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
globenewswire.com
LQDA
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference
globenewswire.com
LQDA
Form 8-K
sec.gov
LQDA
Liquidia Corporation Reports Second Quarter 2026 Financial Results
globenewswire.com
LQDA
Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026
globenewswire.com
LQDA
Form 8-K
sec.gov
LQDA
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions
globenewswire.com
LQDA